{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:49:54Z","timestamp":1740142194761,"version":"3.37.3"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"31","funder":[{"DOI":"10.13039\/100016270","name":"MRC Global Challenges Research Fund","doi-asserted-by":"publisher","award":["MR\/P027987\/1A"],"award-info":[{"award-number":["MR\/P027987\/1A"]}],"id":[{"id":"10.13039\/100016270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Leishmaniasis, a complex disease caused by at least 20 species of unicellular\nparasites of the genus Leishmania, disproportionately affects impoverished regions of\nabout 90 tropical and sub-tropical countries. Currently available antileishmanial therapies,\nparticularly for visceral leishmaniasis, are severely limited, with treatment outcome\ndepending on many factors, including the immune status of the patient, comorbidities,\nmalnutrition, and socio-economic conditions in the patient\u2019s geographic location. There\nis an urgent need for new therapeutics, particularly new effective oral drugs, for visceral\nleishmaniasis. Despite the availability of the Leishmania genome sequence information\nand significant research into the biology of the parasites, antileishmanial drug development\nis hampered by the lack of knowledge about druggable targets in the parasite and\ndifficulties in identifying the molecular targets of compounds that show activity. In this\ncontext, we analyzed recent progress in antileishmanial drug development programs,\nwhich take advantage of different powerful approaches, such as high-throughput screening\nof compound libraries, recent developments in genetic methods for assessing essentiality\nof parasite genes, and chemical, genetic, and proteomics-based target discovery\nand target validation methods.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867328666201125121018","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T05:37:45Z","timestamp":1606369065000},"page":"6337-6357","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antileishmanial Drug Development: A Review of Modern Molecular Chemical Tools and Research Strategies"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3642-2953","authenticated-orcid":true,"given":"Pavan K.","family":"Mantravadi","sequence":"first","affiliation":[{"name":"Analytical Services, Abon Pharmaceuticals, Northvale, NJ07647, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1830-5948","authenticated-orcid":true,"given":"Anutthaman","family":"Parthasarathy","sequence":"additional","affiliation":[{"name":"Rochester Institute of Technology, Thomas H. Gosnell School of Life Sciences, 85 Lomb Memorial Drive, Rochester, NY14623, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-3992","authenticated-orcid":true,"given":"Karunakaran","family":"Kalesh","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Durham University, Lower Mount Joy, South Road, Durham DH1 3LE, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/188378","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/188378\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/188378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T13:45:25Z","timestamp":1633614325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/188378\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":0,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867328666201125121018","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}